Allogene Therapeutics(ALLO) - 2021 Q3 - Earnings Call Transcript

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2021 Earnings Conference Call November 4, 2021 5:00 PM ET Company Participants Christine Cassiano – Chief Communications Officer David Chang – President and Chief Executive Officer Rafael Amado – Executive Vice President of Research and Development and Chief Medical Officer Eric Schmidt – Chief Financial Officer Conference Call Participants Tyler Van Buren – Cowen Michael Schmidt – Guggenheim John Newman – Canaccord Luca Issi – RBC Capital Salveen Richter – Goldm ...